An AllTrials project

NCT02081755: An ongoing trial by Baylor Research Institute

This trial is ongoing. It must report results 1 year, 1 month from now.

Full data

Full entry on ClinicalTrials.gov NCT02081755
Title A 36 Month Multi-center, Open Label, Randomized, Comparator Study to Evaluate the Efficacy and Safety of Everolimus Immunosuppression Treatment in Liver Transplantation for Hepatocellular Carcinoma Exceeding Milan Criteria
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls a "probable Applicable Clinical Trial"
Start date March 31, 2014
Completion date June 30, 2024
Required reporting date June 30, 2025, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Feb. 9, 2024
Days late None